Back to Search Start Over

[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries].

Authors :
Arutyunov AG
Tarlovskaya EI
Galstyan GR
Batluk TI
Bashkinov RA
Arutyunov GG
Belenkov YN
Konradi AO
Lopatin YM
Rebrov AP
Tereshchenko SN
Chesnikova AI
Hayrapetyan HG
Babin AP
Bakulin IG
Bakulina NV
Balykova LA
Blagonravova AS
Boldina MV
Butomo MI
Vaisberg AR
Galyavich AS
Gomonova VV
Grigoryeva NY
Gubareva IV
Demko IV
Evzerikhina AV
Zharkov AV
Zateishchikova AA
Kamilova UK
Kim ZF
Kuznetsova TY
Kulikov AN
Lareva NAV
Makarova EV
Malchikova SV
Nedogoda SV
Petrova MM
Pochinka IG
Protasov KV
Protsenko DN
Ruzanov DY
Saiganov SA
Sarybaev AS
Selezneva NM
Sugraliev AB
Fomin IV
Khlynova OV
Chizhova OY
Shaposhnik II
Schukarev DA
Abdrakhmanova AK
Avetisyan SA
Avoyan HG
Azaryan KK
Aimakhanova GT
Ayypova DA
Akunov AC
Alieva MK
Almukhambedova AR
Aparkina AV
Aruslanova OR
Ashina EY
Badina ONY
Barysheva OY
Batchaeva AS
Bitieva AM
Bikhteev IU
Borodulina NA
Bragin MV
Brazhnik VA
Budu AM
Bykova GA
Vagapova KR
Varlamova DD
Vezikova NN
Verbitskaya EA
Vilkova OE
Vinnikova EA
Vustina VV
Galova EA
Genkel VV
Giller DB
Gorshenina EI
Grigoryeva EV
Gubareva EY
Dabylova GM
Demchenko AI
Dolgikh OY
Duishobaev MY
Evdokimov DS
Egorova KE
Ermilova AN
Zheldybaeva AE
Zarechnova NV
Zimina YD
Ivanova SY
Ivanchenko EY
Ilina MV
Kazakovtseva MV
Kazymova EV
Kalinina YS
Kamardina NA
Karachenova AM
Karetnikov IA
Karoli NA
Karsiev MK
Kaskaeva DS
Kasymova KF
Kerimbekova ZB
Kim ES
Kiseleva NV
Klimenko DA
Klimova AV
Kovalishena OV
Kozlov SV
Kolmakova EV
Kolchinskaya TP
Kolyadich MI
Kondryakova OV
Konoval MP
Konstantinov DY
Konstantinova EA
Kordyukova VA
Koroleva EV
Kraposhina AY
Kryukova TV
Kuznetsova AS
Kuzmina TY
Kuzmichev KV
Kulchoroeva CK
Kuprina TV
Kuranova IAM
Kurenkova LVV
Kurchugina NY
Kushubakova NA
Levankova VI
Ledyaeva AA
Lisun TV
Lisyanskaya VE
Lyubavina NA
Magdeeva NA
Mazalov KV
Mayseenko VI
Makarova AS
Maripov AM
Markov NV
Marusina AA
Melnikov ES
Metlinskaya AI
Moiseenko NB
Muradova FN
Muradyan RG
Musaelyan SN
Nekaeva ES
Nikitina NM
Nifontov SE
Obolentseva EY
Obukhova AA
Ogurlieva BB
Odegova AA
Omarova YV
Omurzakova NA
Ospanova SO
Pavlova VA
Pakhomova EVP
Petrov LD
Plastinina SS
Platonov DA
Pogrebetskaya VAA
Polyakov DV
Polyakov DS
Ponomarenko EEV
Popova LL
Potanin AA
Prokofieva NA
Rabik YD
Rakov NA
Rakhimov AN
Rozanova NA
Samus IV
Serikbolkyzy S
Sidorkina YA
Simonov AA
Skachkova VV
Skvortsova RD
Skuridin DS
Solovieva DV
Solovieva IA
Sukhomlinova IM
Sushilova AG
Tagaeva DR
Titoykina YV
Tikhonova EP
Tokmin DS
Tolmacheva AA
Torgunakova MS
Trenogina KV
Trostyanetskaya NAA
Trofimov DA
Trubnikova MA
Tulichev AA
Tursunova AT
Ulanova ND
Fatenkov OV
Fedorishina OV
Fil TS
Fomina IY
Fominova IS
Frolova IA
Tsvinger SM
Tsoma VV
Cholponbaeva MB
Chudinovskikh TSI
Shavrin IV
Shevchenko OA
Shikhaliev DR
Shishkina EA
Shishkov KY
Shcherbakov SY
Shcherbakova GV
Yausheva EA
Source :
Problemy endokrinologii [Probl Endokrinol (Mosk)] 2023 Jan 24; Vol. 68 (6), pp. 89-109. Date of Electronic Publication: 2023 Jan 24.
Publication Year :
2023

Abstract

Background: There is enough evidence of the negative impact of excess weight on the formation and progression of res piratory pathology. Given the continuing SARS-CoV-2 pandemic, it is relevant to determine the relationship between body mass index (BMI) and the clinical features of the novel coronavirus infection (NCI).<br />Aim: To study the effect of BMI on the course of the acute SARS-COV-2 infection and the post-covid period.<br />Materials and Methods: AKTIV and AKTIV 2 are multicenter non-interventional real-world registers. The АКТИВ registry (n=6396) includes non-overlapping outpatient and inpatient arms with 6 visits in each. The АКТИВ 2 registry (n=2968) collected  the  data  of  hospitalized  patients  and  included  3  visits.  All  subjects  were  divided  into  3  groups:  not  overweight  (n=2139), overweight (n=2931) and obese (n=2666).<br />Results: A higher BMI was significantly associated with a more severe course of the infection in the form of acute kidney injury (p=0.018), cytokine storm (p<0.001), serum C-reactive protein over 100 mg/l (p<0.001), and the need for targeted therapy (p<0.001) in the hospitalized patients. Obesity increased the odds of myocarditis by 1,84 times (95% confidence interval [CI]: 1,13-3,00) and the need for anticytokine therapy by 1,7 times (95% CI: 1,30-2,30).The  patients  with  the  1st  and  2nd  degree  obesity,  undergoing  the  inpatient  treatment,  tended  to  have  a  higher  probability  of  a  mortality  rate.  While  in  case  of  morbid  obesity  patients  this  tendency  is  the  most  significant  (odds  ratio  -  1,78; 95% CI: 1,13-2,70). At the same time, the patients whose chronical diseases first appeared after the convalescence period, and those who had certain complaints missing before SARS-CoV-2 infection, more often had BMI of more than 30 kg/m2 (p<0,001).Additionally, the odds of death increased by 2,23 times (95% CI: 1,05-4,72) within 3 months after recovery in obese people over the age of 60 yearsCONCLUSION.  Overweight  and/or  obesity  is  a  significant  risk  factor  for severe  course  of  the  new  coronavirus  infection  and  the associated cardiovascular and kidney damage Overweight people and patients with the 1st and 2nd degree obesity tend to have a high risk of death of SARS-CoV-2 infection in both acute and post-covid periods. On top of that, in case of morbid obesity patients this tendency is statistically significant. Normalization of body weight is a strategic objective of modern medicine and can contribute to prevention of respiratory conditions, severe course and complications of the new coronavirus infection.

Details

Language :
Russian
ISSN :
2308-1430
Volume :
68
Issue :
6
Database :
MEDLINE
Journal :
Problemy endokrinologii
Publication Type :
Academic Journal
Accession number :
36689715
Full Text :
https://doi.org/10.14341/probl13165